Fig. 1From: Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditionsIllustration of the different steps of the study. BCCP Belgian Commission on Clinical Pathology, INAMI-RIZIV National Institute for Health and Disability Insurance, RD Royal Decree, RDWG Rare Diseases Working Group, RLs Reference laboratoriesBack to article page